VEGFR-2 DNA Vaccine VXM01

An orally available DNA cancer vaccine containing an attenuated strain of the bacterium Salmonella typhimurium encoding murine vascular endothelial growth factor receptor 2 (VEGFR-2) (VXM01), with potential immunomodulating, anti-angiogenic and antineoplastic activity. Upon oral administration and successful transduction, VEGFR-2 DNA vaccine VXM01 expresses VEGFR-2 in addition to inducing the expression of T-cell activation markers, such as CD25, interleukin-2, the early T-cell activation antigen CD69 and the lymphocyte function-associated antigen LFA-2. The immune response targets the fast growing VEGFR-2 expressing endothelial cells found in the tumor vasculature, thereby blocking angiogenesis which may ultimately inhibit tumor cell proliferation. VEGFR-2 is a receptor tyrosine kinase overexpressed on proliferating endothelial cells in the tumor vasculature. (NCI Thesaurus)

YOU MAY ALSO LIKE

VEGFR tyrosine kinase inhibitor

A substance that blocks an enzyme needed to form blood vessels. Also called vascular endothelial growth factor receptor tyrosine kinase inhibitor. …

VEGFR Inhibitor KRN951

An orally bioavailable quinoline-urea derivative inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1 and 2 with potential antiangiogenesis and antineoplastic…

VEGFC wt Allele

Human VEGFC wild-type allele is located within 4q34.1-q34.3 and is approximately 109 kb in length. This allele, which encodes vascular endothelial growth…

VEGFC Gene

This gene plays a role in vasculogenesis.

VEGFB wt Allele

Human VEGFB wild-type allele is located in the vicinity of 11q13 and is approximately 4 kb in length. This allele, which encodes…

VEGFB Gene

This gene plays a role in regulation of blood vessel physiology.